[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Covid autoimmunity", "description": "Covid toe, caused by the immune response to the virus, not the virus itself\n\nhttps://covidskinsigns.com\n\nhttps://onlinelibrary.wiley.com/doi/full/10.1111/bjd.20707\n\nObjectives\n\nTo study skin and blood endothelial and immune system activation\n\nIn chilblain-like lesions (CLL),\n\nCLL in comparison with healthy controls and seasonal chilblains (SC)\n\n(cold-induced sporadic chilblains occurring during 2015 and 2019)\n\nMethods\n\nObservational study\n\nSaint-Louis Hospital, Paris, France\n\nN = 50\n\nCytokine assays\n\nAssessment of interferon-stimulated gene expression in whole blood\n\nSoluble markers of endothelial activation and/or angiogenesis\n\nHistological examinations\n\nLateral flow spike assay\n\nCirculating endothelial cell counting\n\nStatistical analysis\n\nResults\n\nHistological patterns were similar in CLL and SC groups\n\nTranscriptomic signatures overlapped in both the CLL and SC groups\n\nType I interferon\n\nCytotoxic\u2013natural killer gene signature\n\nCLL were characterized by higher IgA tissue deposition\n\nMore complement and angiogenesis factors in CLL compared with SC\n\nAutoimmune vasculitis\n\nConfirmed endothelial dysfunction in CLL\n\nMicroangiopathy leading to clinical chilblains\n\nDisrupt the thrombo-protective state of endothelial cells\n\nLikely contributing to microvascular thrombosis\n\nSystemic endothelial activation?\n\nThe PT ratio and aPTT were normal in all patients\n\nOnly three patients (6%) had a moderate increase in D-dimer levels\n\nConclusions\n\nInflammation in the skin in CLL\n\nAssociated with endothelial alteration\n\nImmune infiltration of cytotoxic and type I IFN-leading to clinical manifestations\n\nhttps://www.bbc.co.uk/news/health-58801462\n\nUK podiatrist Dr Ivan Bristow\n\nlike the regular chilblains typically seen during cold spells and in people who have problems with circulation - the lesions usually go away on their own. \n\nBut some may need treatment with creams and other drugs.\n\nThe confirmation of the cause will help to develop new treatments to manage it more effectively\n\n\nDr Veronique Bataille, consultant dermatologist, British Skin Foundation\n\nCovid toe was seen very frequently during the early phase of the pandemic, but has been less common in the current Delta variant wave.\n\nThat might be down to more people being vaccinated or having some protection against Covid from past infections. \n\nPresentations after vaccination are much rarer\n\nDelayed presentation my mean link is missed\n\nFree download my two comprehensive but free educational text books (over 50,000 downloads so far) or make a donation to the campbellteaching project using this link: http://159.69.48.3", "link": "https://www.youtube.com/watch?v=wQH40UydmWM", "date_published": "2021-10-08 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Most common symptoms and immunity", "description": "Runny nose, 76%. Headache, 75%  Sneezing, 66%  Sore throat, 52%  Loss of smell, 52%\n\nhttps://covid.joinzoe.com/blog\n\nhttps://www.youtube.com/watch?v=xoGqyFUoUSw\n\nMost common symptoms in vaccinated and children\n\nRunny nose, 76%\n\nHeadache, 75%\n\nSneezing, 66%\n\nSore throat, 52%\n\nLoss of smell, 52%\n\n(Fever nor chronic cough in the top symptoms)\n\nOut of date government advice misses 40% of infections\n\nNatural immunity, levels of protection against reinfection\n\nNatural infection alone in past year, 65%\n\n2 doses of AZ in past 6 months, 71%\n\n2 doses of Pfizer in past 6 months, 83%\n\nInfection (past year) followed by 2 doses of AZ, 90%\n\nInfection (past year) followed by 2 doses of Pfizer, 94%\n\nContradicts Israeli data\n\nProtection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel \n\nhttps://www.medrxiv.org/content/10.1101/2021.04.20.21255670v1.full.pdf\n \nProtection from prior SARS-CoV-2 infection, 94\u00b78%\n\nHospitalization 94\u00b71% \n\nSevere illness 96\u00b74%", "link": "https://www.youtube.com/watch?v=6Gn5GtUpwQ0", "date_published": "2021-10-07 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]